Trials / Completed
CompletedNCT02554136
Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816
An Open-labeled, Randomized Crossover Study to Evaluate the Pharmacokinetic Interaction and Safety After Single Oral Administration of HGP0918 and HGP0816 in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The investigators investigate the potential pharmacokinetic drug-drug interaction between HGP0918 and HGP0816 in healthy adult subjects who receive HGP0918 alone, HGP0816 alone, and both together in a 3 period repeatedly
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HGP0918 | |
| DRUG | HGP0816 | |
| DRUG | HGP0918 + HGP0816 |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-09-18
- Last updated
- 2015-09-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02554136. Inclusion in this directory is not an endorsement.